TransCode Therapeutics, Inc. (RNAZ) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 16.75M | 21.98M | 4.75M | 8.24M | 13.04M | 7.09M | 3.61M | 4.39M | 6.71M | 4.46M | 9.37M | 4.89M |
| Cash & Short-Term Investments | 12.84M | 17.81M | 2.84M | 7.37M | 11.57M | 5.81M | 1.88M | 3.35M | 4.91M | 2.77M | 7.45M | 3.57M |
| Cash Only | 12.84M | 17.81M | 2.84M | 7.37M | 11.57M | 5.81M | 1.88M | 3.35M | 4.91M | 2.77M | 7.45M | 3.57M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.3M | 3.25M | 198.3K | 176.12K | 322.44K | 0 | 11.95K | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.02M | 529.04K | 1.34M | 297.92K | 680.95K | 517.48K | 772.87K | 532.46K | 1.48M | 1.14M | 1.08M | 759.55K |
| Total Non-Current Assets | 140.42M | 140.41M | 475.63K | 24.69K | 149.99K | 201.16K | 323.52K | 438.17K | 576.45K | 714.26K | 854.43K | 988.61K |
| Property, Plant & Equipment | 346.75K | 370.68K | 19.91K | 24.69K | 38.13K | 89.31K | 211.66K | 326.31K | 464.59K | 602.4K | 742.57K | 876.75K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 25.74M | 25.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 114.3M | 114.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 25K | 0 | 455.73K | 0 | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K |
| Total Assets | 157.16M | 162.4M | 5.23M | 8.27M | 13.19M | 7.29M | 3.94M | 4.82M | 7.29M | 5.17M | 10.23M | 5.88M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 1091.18% | 2126.32% | 32.79% | 71.34% | 80.98% | 41.1% | -61.52% | -17.97% | 30.41% | -31.87% | -14.88% | -58.45% |
| Total Current Liabilities | 5.38M | 3.49M | 2.97M | 1.56M | 2.51M | 2.77M | 2.28M | 3.5M | 2.71M | 3.49M | 5.6M | 3.52M |
| Accounts Payable | 5M | 0 | 0 | 1.36M | 2.43M | 2.58M | 1.97M | 0 | 0 | 2.33M | 4.86M | 0 |
| Days Payables Outstanding | 18.8K | - | - | - | - | - | 1.42K | - | - | 2.36K | 3.22K | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 38.29K | 152.48K | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.06K | 54.31K | 81.75K |
| Other Current Liabilities | 128.5K | 0 | 0 | -1.36M | -2.43M | 26.11K | 46.41K | 0 | 0 | -2.33M | -4.86M | 0 |
| Current Ratio | 3.11x | 6.29x | 1.60x | 5.27x | 5.20x | 2.56x | 1.58x | 1.25x | 2.48x | 1.28x | 1.67x | 1.39x |
| Quick Ratio | 3.11x | 6.29x | 1.60x | 5.27x | 5.20x | 2.56x | 1.58x | 1.25x | 2.48x | 1.28x | 1.67x | 1.39x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.27M | 148.57M | 832.88K | 553.71K | 392K | 6.54M | 0 | 0 | 0 | 38.29K | 189.77K | 265.65K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38.29K | 189.77K | 265.65K |
| Deferred Tax Liabilities | 457.38K | 226.07K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 6.81M | 148.34M | 832.88K | 553.71K | 392K | 6.54M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 12.64M | 152.06M | 3.8M | 2.12M | 2.9M | 9.31M | 2.28M | 3.5M | 2.71M | 3.53M | 5.79M | 3.79M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 38.29K | 152.48K | 227.25K | 339.41K | 450.57K | 594.69K | 663.29K |
| Net Debt | -12.84M | -17.81M | -2.84M | -7.37M | -11.57M | -5.77M | -1.72M | -3.13M | -4.57M | -2.32M | -6.86M | -2.91M |
| Debt / Equity | - | - | - | - | - | - | 0.09x | 0.17x | 0.07x | 0.27x | 0.13x | 0.32x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -24384.69x | -813.77x | - | -106011.39x | -3228.23x | -214.10x | -1157.15x | -341.76x | -72.12x | - | -553.57x |
| Total Equity | 144.52M | 10.34M | 1.43M | 6.15M | 10.29M | -2.02M | 1.65M | 1.32M | 4.58M | 1.64M | 4.44M | 2.09M |
| Equity Growth % | 1304.07% | 611.98% | -13.69% | 364.93% | 124.53% | -223.03% | -62.79% | -36.81% | 2036% | -49.37% | -46.15% | -83.16% |
| Book Value per Share | 157.61 | 11.27 | 1.71 | 7.37 | 59.75 | -5.67 | 4.64 | 6.19 | 29.42 | 305.54 | 40.58 | 68.62 |
| Total Shareholders' Equity | 144.52M | 10.34M | 1.43M | 6.15M | 10.29M | -2.02M | 1.65M | 1.32M | 4.58M | 1.64M | 4.44M | 2.09M |
| Common Stock | 92 | 92 | 84 | 84 | 2.33K | 103 | 1.73K | 727 | 581 | 63 | 1.07K | 195 |
| Retained Earnings | -115.65M | -97.86M | -84.42M | -79.56M | -75.29M | -63.2M | -57.26M | -54.93M | -49.74M | -46.42M | -42.33M | -37.03M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |